You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 122 No. 6, June 1986 TABLE OF CONTENTS
  Archives
  •  Online Features
  STUDIES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Treatment of Bullous Pemphigoid With Tetracycline and Niacinamide

A Preliminary Report

Mark Allan Berk, MD, FRCP(C); Allan L. Lorincz, MD

Arch Dermatol. 1986;122(6):670-674.


Abstract

• Patients with moderate to severe bullous pemphigoid are usually treated with systemic corticosteroids. Four patients were treated with tetracycline hydrochloride and niacinamide because of the steroid-sparing anti-inflammatory properties of these agents. An excellent clinical response free of side effects was observed in all patients. The lesions recurred whenever treatment was discontinued. It is believed that these drugs suppress the complement-mediated inflammatory response at the basement membrane zone by suppressing neutrophil chemotaxis and mediators of the inflammatory response in this bullous disease.

(Arch Dermatol 1986;122:670-674)



Author Affiliations

From the Section of Dermatology, Department of Medicine, The University of Chicago, Pritzker School of Medicine.


Footnotes

Accepted for publication Jan 7, 1986.

Reprint requests to the Section of Dermatology, Department of Medicine, The University of Chicago, Pritzker School of Medicine, 5841 S Maryland Ave, Box 409, Chicago, IL 60637 (Dr Berk).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Nicotinamide: a potential addition to the anti-psoriatic weaponry
NAMAZI
FASEB J. 2003;17:1377-1379.
ABSTRACT | FULL TEXT  

Consensus Statement on the Use of Intravenous Immunoglobulin Therapy in the Treatment of Autoimmune Mucocutaneous Blistering Diseases
Ahmed and Dahl
Arch Dermatol 2003;139:1051-1059.
ABSTRACT | FULL TEXT  

Treatment of cutaneous calcinosis in limited systemic sclerosis with minocycline
Robertson et al.
Ann Rheum Dis 2003;62:267-269.
ABSTRACT | FULL TEXT  

Minocycline-Induced Hyperpigmentation in Patients With Pemphigus and Pemphigoid
Ozog et al.
Arch Dermatol 2000;136:1133-1138.
ABSTRACT | FULL TEXT  

Bullous Pemphigoid: The Latest in Diagnosis, Prognosis, and Therapy
Korman
Arch Dermatol 1998;134:1137-1141.
FULL TEXT  

Vesicobullous Lesions in a Child
Nyul et al.
Arch Dermatol 1997;133:779-780.
ABSTRACT  

Management of Acquired Bullous Skin Diseases
Fine
NEJM 1995;333:1475-1484.
FULL TEXT  

Is the Combination of Tetracycline and Nicotinamide Therapy Alone Effective in Pemphigus?
Alpsoy et al.
Arch Dermatol 1995;131:1339-1340.
ABSTRACT  

Nicotinamide and Tetracycline Therapy of Bullous Pemphigoid
Fivenson et al.
Arch Dermatol 1994;130:753-758.
ABSTRACT  

Dermatology and the Evolution of Therapies to Control Inflammatory Tissue Injury
Lorincz
Arch Dermatol 1994;130:781-782.
ABSTRACT  

Controlled Trial of Azathioprine and Plasma Exchange in Addition to Prednisolone in the Treatment of Bullous Pemphigoid
Guillaume et al.
Arch Dermatol 1993;129:49-53.
ABSTRACT  

A Peculiar Case of Linear IgA Bullous Dermatosis
Fuligni et al.
Arch Dermatol 1991;127:126-127.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.